HB 4294 Oklahoma House · 2026 Regular Session

Health insurance; fair coverage; epilepsy; termination of coverage; devices; surgeries; effective date.

HB 4294 requires health insurers in Oklahoma to provide equal coverage for epilepsy as for other conditions, prohibiting termination or non-renewal of policies solely due to an epilepsy diagnosis. It mandates coverage for seizure prevention devices, surgeries, or medical procedures prescribed by an epilepsy specialist when medically necessary to reduce SUDEP (sudden unexpected death in epilepsy) risk. The law applies to all individual and group health insurance plans covering medical/surgical benefits and takes effect November 1, 2026. This directly affects epilepsy patients and insurers offering such coverage in Oklahoma.
Bill status vetoed 4 of 5 stages cleared
Introduction
Feb 2026
Committee Review
May 2026
House Passage
May 2026
Senate Passage
Apr 2026
Vetoed
May 2026
Introduced Feb 2, 2026 Vetoed May 12, 2026
Maddy AI version diff · 8 comparisons

What changed between versions

Floor (House) Floor (Senate) · 3 edits
MINOR
The bill was amended to move from the House to the Senate floor, resulting in a significant restructuring of the text. The most substantive change is the reordering of the bill's sections: the effective date was moved to Section 2, and a new Section 2 was added containing the original Section 2 content. Additionally, the committee report attribution was updated to reflect the Senate Health and Human Services Committee instead of the Commerce Committee.
Scope change
The bill's scope and applicability remain unchanged; it still mandates equal health insurance coverage for individuals with epilepsy and covers neurostimulation devices. The changes are primarily organizational and procedural, affecting the bill's structure and committee attribution rather than its legal requirements.
TECHNICAL

The bill's title page and header information were updated to reflect the Senate Floor Version, including the date April 20, 2026, and the specific committee sponsors.

The bill's text was reorganized; the original Section 2 (effective date) was moved to Section 2, and a new Section 2 was inserted containing the original Section 2 text regarding neurostimulation devices.

The committee report attribution was changed from the House Committee on Commerce and Economic Development Oversight to the Senate Committee on Health and Human Services.

Floor votes · Senate Apr 29, 2026 · House Mar 24, 2026

How they voted

2917
Passed · 4 other
Total votes 50
Apr 29, 2026
D Democratic9
8 Yea 1 Nay
88% Yea
R Republican41
21 Yea 16 Nay 4
51% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
36
Key actions
10
Committee
8
Amendments
1
May 12, 2026
Vetoed
Vetoed 05/12/2026
lower
May 5, 2026
Committee
Referred for enrollment
lower
May 5, 2026
Lower · Passed
Fourth Reading, Measure passed: Ayes: 55 Nays: 30
lower
May 5, 2026
Lower · Passed
SA's read, adopted
lower
Apr 30, 2026
Upper · Passed
Engrossed to House
upper
Apr 29, 2026
Committee
Referred for engrossment
upper
Apr 29, 2026
Upper · Passed
Measure passed: Ayes: 28 Nays: 16
upper
Apr 20, 2026
Upper · Passed
Reported Do Pass as amended Health and Human Services committee; CR filed
upper
Apr 9, 2026
Committee
Referred to Health and Human Services
upper
Mar 25, 2026
Introduced
First Reading
upper
Mar 25, 2026
Lower · Passed
Engrossed, signed, to Senate
lower
Mar 24, 2026
Committee
Referred for engrossment
lower
Mar 24, 2026
Lower · Passed
Third Reading, Measure passed: Ayes: 63 Nays: 32
lower
Mar 24, 2026
Lower · Passed
Amended
lower
Mar 4, 2026
Lower · Passed
CR; Do Pass, amended by committee substitute Commerce and Economic Development Oversight Committee
lower
Feb 19, 2026
Lower · Passed
Policy recommendation to the Commerce and Economic Development Oversight committee; Do Pass, amended by committee substitute Insurance
lower
Feb 3, 2026
Committee
Referred to Insurance
lower
Feb 2, 2026
Introduced
First Reading
lower
2 primary · 0 co-sponsors

Sponsors